https://www.selleckchem.com/products/GDC-0449.html
Rationale Compromised protein quality control can result in proteotoxic intracellular protein aggregates in the heart, leading to cardiac disease and heart failure. Defining the participants and understanding the underlying mechanisms of cardiac protein aggregation is critical for seeking therapeutic targets. We identified ubiquitin-conjugating enzyme E2 variant 1 (Ube2v1) in a genome-wide screen designed to identify novel effectors of the aggregation process. However, its role in the cardiomyocyte is undefined. Objective To assess whe
Like
Comment
Share
